Saleh W A, Burkman R T, Zacur H A, Kimball A W, Kwiterovich P, Bell W K
Department of Gynecology and Obstetrics, Henry Ford Hospital, Detroit, MI 48202.
Am J Obstet Gynecol. 1993 Jun;168(6 Pt 1):1740-5; discussion 1745-7. doi: 10.1016/0002-9378(93)90685-c.
Our purpose was to determine the relationship between bioavailability of contraceptive steroids and bleeding patterns.
A randomized clinical trial evaluated 192 women on 50 micrograms of ethinyl estradiol and 1.0 mg of norethindrone (OC1), 35 micrograms ethinyl estradiol and 1.0 mg of norethindrone (OC2), and 35 micrograms ethinyl estradiol and 0.5 mg norethindrone (OC3) over nine cycles.
Intermenstrual bleeding rates were higher for OC3 when compared with OC1 (p = 0.01). The number of intermenstrual bleeding days was highest for OC3 (p = 0.001) and higher for OC2 when compared with OC1 (p < 0.006). The onset of withdrawal bleeding occurred faster in OC3 patients (p < 0.02). Bioavailability of both contraceptive steroids as measured by baseline values and 1-hour slopes did not correlate with bleeding patterns at 3, 6, and 9 months of use.
These data suggest that differences in biologic responses associated with pill use cannot be explained solely on the basis of these particular hormone measurements.
我们的目的是确定避孕甾体激素的生物利用度与出血模式之间的关系。
一项随机临床试验对192名女性进行了为期九个周期的评估,她们分别服用含50微克炔雌醇和1.0毫克炔诺酮的避孕药(OC1)、含35微克炔雌醇和1.0毫克炔诺酮的避孕药(OC2)以及含35微克炔雌醇和0.5毫克炔诺酮的避孕药(OC3)。
与OC1相比,OC3的经间期出血率更高(p = 0.01)。OC3的经间期出血天数最多(p = 0.001),与OC1相比,OC2的经间期出血天数也更多(p < 0.006)。OC3组患者撤退性出血的发生更快(p < 0.02)。通过基线值和1小时斜率测量的两种避孕甾体激素的生物利用度与使用3个月、6个月和9个月时的出血模式均无相关性。
这些数据表明,与服用避孕药相关的生物学反应差异不能仅基于这些特定的激素测量结果来解释。